Recent Comments
- Joy Smith on The Declaration of Pandemics
- Linnea Comstock on The Declaration of Pandemics
- Lance W Richardson on The Declaration of Pandemics
- Sarah on The Declaration of Pandemics
- Bill on The Declaration of Pandemics
Most Viewed Posts
- Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market (19,554)
- Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA (16,765)
- New treatment paradigm for C. Diff colitis (15,077)
- Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs (15,001)
- I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show (14,552)
- How the FDA regulates compounding pharmacies (14,411)
- The Healthcare Channel hits 10 (14,126)
- The new CDC guidelines for prescribing opioid pain pills (9,513)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (9,180)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (8,779)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Category Archives: Cardiology
Man who oversaw one of the biggest academic research frauds in medical history is poised to become the next FDA Commissioner
Update February 7, 2016- Key senators, including Bernie Sanders, are now threatening to filibuster
Posted in - Opinion, - Policy, Cardiology, FDA, NIH
Leave a comment
Are the new PCSK9 cholesterol lowering drugs worth the high cost?
December 16, 2015- Interviewed by Steven E. Greer, MD
Posted in - Biotech, - NEJM, - Opinion, - Pharma, - Policy, Cardiology, CMS, FDA
Leave a comment
Review of the TCT 2015 data
October 19, 2015
Posted in - Medical Devices, Cardiac surgery, Cardiology, Henry Ford
Leave a comment
Review of the TAVR data from the 2015 ACC
May 7, 2015- Interviewed by Steven E. Greer, MD
Posted in - Medical Devices, Cardiac surgery, Cardiology, UCLA
Leave a comment
The Sapien 3 TAVR valve
September 9, 2015- By Steven E. Greer, MD We interviewed William O’Neill, MD, a principal investigator for the Edwards Lifesciences Sapien valve trials,
Posted in Cardiology
Leave a comment
Can a “calculator” really tell doctors who should be on Lipitor?
November 13, 2013- By Steven E. Greer, MD The AHA released the long-awaited new guidelines that recommend which patients should be
Posted in Cardiology, Uncategorized
Leave a comment
The newly approved Edwards Lifesciences Sapien 3 aortic valve
July 5, 2015- Interviewed by Steven E. Greer, MD We interviewed William Suh, MD of UCLA about the newly approved Edwards Lifesciences Sapien
Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, UCLA
Leave a comment
Astronaut and Senator John Glenn suffers stroke after TAVR
May 14, 2015- By Steven E. Greer, MD Stroke is the bane of TAVR. In the Edwards Lifesciences Sapien valve, stroke rates exceed 10%.
Posted in - Medical Devices, - Opinion, Cardiology
Leave a comment
The PCSK9 LDL drugs do not cut heart risk in half
March 18, 2015- Op-Ed by Steven E. Greer, MD The American College of Cardiology (ACC) meeting is underway, and the main Late Breaking data
Occluding the left atrial appendage to prevent stroke in A-fib
May 17, 2014- Thromboembolic stroke caused by atrial fibrillation is the primary reason patients are placed
Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, Henry Ford
Leave a comment
Drug-coated balloons to treat fem-pop disease
April 27, 2014– Interviewed by Steven E. Greer, MD At the Charing Cross symposium in London, Medtronic reported results of the IN-PACT trial
Posted in - Medical Devices, Cardiac surgery, Cardiology, UCLA
Leave a comment
How many stent cases does it take to bill Medicare for $18 Million?
April 9, 2014- By Steven E. Greer, MD The release of data by Medicare showing what each doctor earns from billing CMS is making news for
Posted in Cardiac surgery, Cardiology, CMS, Congress
Leave a comment
The subcutaneous ICD
The concept of applying high voltage to shock a heart out of
Posted in - Medical Devices, Cardiac surgery, Cardiology, UCLA
Leave a comment
The ACC seems to support dangerous energy drinks
March 6, 2014- By Steven E. Greer, MD The Maryland State Assembly will begin debate on a bill to regulate “energy drinks”, such as those
Posted in - Policy, Cardiology
Leave a comment
The FDA discusses Brilinta
February 4, 2014- The WSJ is reporting today on a Johns Hopkins doctor who filed a federal
Posted in - Pharma, Cardiology, FDA
Leave a comment
CBS allows TV doctor to make egregious claims about statins
Can a “calculator” really tell doctors who should be on Lipitor? Nortin Hadler, MD: lack of evidence for widespread statin use The risk of diabetes associated with statin drugs “You’re telling me this now?” Why the news is suddenly critical … Continue reading
Posted in - Pharma, Cardiology, Cedars Sinai
Leave a comment
The finances of TAVI: do prices have to come down?
November 8, 2013- Interviewed by Steven E. Greer, MD William O’Neill, MD of Henry Ford discusses the finances of transapical aortic valve implantation (TAVI) and why the $30,000 pricetag for the devices should be closer to $5,000. He also discusses … Continue reading
Posted in - Medical Devices, Cardiac surgery, Cardiology, CMS
Leave a comment
TAVI: Comparing CoreValve to Sapien
November 8, 2013- Interviewed by Steven E. Greer, MD William O’Neill, MD of Henry Ford discusses the recent pivotal data for the Medtronic CoreValve device,
Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, Henry Ford
Leave a comment
The more we know, the more unnecessary President Bush’s stent seems
October 16, 2013 By Steven E. Greer, MD A recent short article in an obscure Washington, DC wonky journal triggered national media
Posted in Cardiac surgery, Cardiology
Leave a comment
Serelaxin to treat acute heart failure
July 8, 2013- The FDA granted Novartis the coveted “Breakthrough” status for drug serelaxin
Posted in Cardiology, UCLA
Leave a comment